GANX
GANX
BiotechnologyMarket Cap
N/A
Float
N/A
Short Interest
0.0%
Predictions
0
Hit Rate
N/A
Price Chart
Powered by TradingViewTechnical Analysis
Company Profile
GANX
NASDAQ NMS - GLOBAL MARKET
US
Biotechnology
Currency
USD
USD
Short Interest
0.00%
0.00%
Revenue
Yes
Yes
Upcoming Catalysts
EARNINGS
Q4 earnings report for GANX (EPS est: $-0.1479)
Mar 19, 2026
No predictions yet for this ticker.